Other OTC - Delayed Quote USD

Zicix Corporation (ZICX)

0.0006 0.0000 (0.00%)
At close: April 12 at 2:07 PM EDT
Loading Chart for ZICX
DELL
  • Previous Close 0.0006
  • Open 0.0006
  • Bid --
  • Ask --
  • Day's Range 0.0006 - 0.0006
  • 52 Week Range 0.0005 - 0.0014
  • Volume 300
  • Avg. Volume 275,512
  • Market Cap (intraday) 551,445
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.

www.zicixgroup.com

2

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: ZICX

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZICX
33.11%
S&P 500
4.14%

1-Year Return

ZICX
24.75%
S&P 500
19.55%

3-Year Return

ZICX
92.28%
S&P 500
18.68%

5-Year Return

ZICX
97.99%
S&P 500
70.99%

Compare To: ZICX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZICX

Valuation Measures

As of 4/18/2024
  • Market Cap

    549.61k

  • Enterprise Value

    549.61k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -53.38k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

People Also Watch